Tabituximab Barzuxetan Biosimilar Antibody Conjugate (FZD10) for Research

Cat No.: GMP-Bios-INN-1001

Pre-made Tabituximab Barzuxetan benchmark antibody (Whole mAb ADC, anti-FZD10 therapeutic antibody, Anti-CD350/FZ-10/Fz10/FzE7/hFz10 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.



Order Information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. →
Catalog No. Package Price(In USD)
GMP-Bios-INN-1001-1mg 1mg
GMP-Bios-INN-1001-10mg 10mg
GMP-Bios-INN-1001-100mg 100mg
GMP-Bios-INN-1001-xmg ≥100mg



Product Details

Products Name (INN Index) Pre-Made Tabituximab Barzuxetan Biosimilar, Whole Mab Adc, Anti-Fzd10 Antibody: Anti-CD350/FZ-10/Fz10/FzE7/hFz10 therapeutic antibody Drug Conjugate
INN Name Tabituximab Barzuxetan
TargetFZD10
FormatWhole mAb ADC
DerivationChimeric
Species Reactivityhuman
CH1 IsotypeIgG1 - kappa
VD LCIgG1 - kappa
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
CompaniesOncoTherapy Science Inc. (Kawasaki Japan)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech0



About target - FZD10

1. Protein Frizzled-10

2. Gene FZD10

3. Organism Homo sapiens (Human)

Function
Receptor for Wnt proteins. Functions in the canonical Wnt/beta-catenin signaling pathway (By similarity).
The canonical Wnt/beta-catenin signaling pathway leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes. A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues (Probable).